Tuesday, June 8th, 2010
1:00 p.m. to 2:00 p.m. Eastern (10:00 - 11:00 a.m. Pacific)
Click here to find out what time your event starts in your time zone.
  Register for $195
Call 209.577.4888 or
Click here to register
      Convergence of Consumerism, Genomics and The Internet
     
Customization of Dx, Tx and Rx under a patient-centered model of care
 
 
      Change Drivers: Chronic disease; Digitization; & Convergence of behavior, socio-economic & genetic factors
     
Six key areas around which health systems will incorporate customization for patient-centered care
     
Examples of new health delivery models in the future and touch points of care that are customized
     
Specific recommendations to build towards a patient-centered model of care customized to individuals
      Based on in-depth global research from PricewaterhouseCoopers Health Research Institute
  Benjamin Isgur
Director,
PricewaterhouseCoopers LLP’s
Health Research Institute
 
 
Overview
  
This presentation will identify and discuss significant trends reshaping health systems around the world, namely the creation of a new, more efficient primary health system, one that is patient centered and takes into account the evolving power of individuals. The session will delve into the profound impact that consumerism, genomics and the Internet have had on healthcare and how the combination of these forces has laid the groundwork for a more patient-centered health system over the next decade.

The main thesis is that care, in the future, will be customized to individuals as performance metrics, payment, outcomes, incentives, services and treatments address differences in their needs and preferences and as the focus of health systems shifts from reactive medicine to prevention and cure. This thesis is based on a year-long study by PricewaterhouseCoopers Health Research Institute, including interviews with 200 health leaders in 25 countries around the world.

The session will include four sections:

  1. In-depth examination of three predominant drivers of the change: 1) Chronic diseases, 2) Digitization: 3) A broader view of the converged health influences of behavioral, socio-economic and genetic factors that are not within the control of today’s medical delivery system.
  2. Exploration six key areas around which health systems are likely to incorporate customization as they build a system of patient-centered care. These areas include incentive based payment, funding mechanisms, patient communication, workforce, broad-based regulatory reforms and electronic medical records.
  3. Examples of new health delivery models in the future and touch points of care that are customized.
  4. Specific recommendations for health leaders as they work toward a patient-centered model of care customized to individuals.

Observations and recommendations will be tailored to the needs of healthcare stakeholders who have the responsibility of guiding health systems and organizational growth and adaptation. The presentation will cut across all health segments—health systems, physicians, insurers, pharmaceutical companies, medical devices and life sciences and will present a blueprint for change that session participants can incorporate into their respective planning processes. The discussion will examine policy and societal changes, scientific development, technology and cultural expectations.

The basis of this presentation rests on the data and analysis laid out in a paper published by PricewaterhouseCoopers’ Health Research Institute, entitled HealthCast: The Customization of Diagnosis, Care and Cure. The report reflects proprietary research conducted by PwC, including more than 200 in-depth interviews in 25 countries with thought leaders and executives representing government, hospitals, pharmaceutical companies, insurance companies, clinicians, academics and the business community and a survey of 3,500 individuals in seven countries and 590 leaders of health plans, providers, government, employers, physician groups and pharmaceutical/life science firms in 20 countries.

 
Learning Objectives
 
Discussion topics include:
  • In-depth review of the various scientific and technological advancements that will enable “mass customization in healthcare”.
  • How communication and education are the key variables that will alter every aspect of the healthcare business--from patient-physician relationship to drug development to new services, and the opportunity they represent for non-traditional, new entrants to the field of healthcare.
  • How funding methodologies will change in order to better meet the goal of more efficient, personalized care by including incentives that better align with best practices.
  • How the patient will emerge as the primary driver in the management of their own chronic care.
  • Most effective strategies for engaging patients proactively in managing their health.
  • The language of a re-imagined health delivery system—definitions and descriptions of coordinated care teams, patient experience benchmarks, care-anywhere networks, fluent navigators and medical proving grounds.
  • Definition of terms
     
Who Should Attend
  
Interested attendees would include:
  • C-Suite Executives
  • Strategy, Planning and Policy Executives and Staff
  • Medical Directors
  • Clinical Executives
  • Business Development Executives
  • Business, Clinical and Market Intelligence Staff
  • Other Interested Parties

Attendees would represent organizations including:

  • Hospitals
  • Provider Networks
  • Medical Groups
  • Health Plans and Insurance Companies
  • Pharmaceutical Organizations and PBMs
  • Medical Device Companies
  • Care Management Organizations
  • Health Technology Companies
  • Solutions Providers
  • Associations, Institutes and Research Organizations
  • Media and other Interested Organizations
Registration
  
Individual Registration Fee: $195
. Audio Conference CD-ROM: $40 for attendees; $255 for non-attendees after the event.

Corporate Site licensing also available. Click here to register or call 209.577.4888 We look forward to your participation in this event!

 
Faculty
 
 
 

Benjamin Isgur
Director, PricewaterhouseCoopers LLP’s Health Research Institute

 

 

Benjamin Isgur is the Director of PricewaterhouseCoopers LLP’s Health Research Institute. As Director, Mr. Isgur develops national and global thought leadership and research initiatives for the firm and clients. HRI is a dedicated research group that provides new intelligence, perspective, and analysis on major health-related business issues. He also consults with healthcare systems, trade associations, and policy groups on strategic planning, and industry intelligence and trends.

Mr. Isgur has worked extensively with health policy and industry associations including, American Hospital Association (AHA), Texas Hospital Association (THA), Indiana Health and Hospital Association (IHHA), Healthcare Financial Management Association (HFMA), Assisted Living Federation of America (ALFA), Pharmaceutical Care Management Association (PCMA), Texas Institute of Health Policy Research (TIHPR), and the California Healthcare Foundation (CHCF). Mr. Isgur has published numerous reports and spoken on health subjects such as, government health policy, workforce strategies, hospital charity care and community benefit, consumerism, and the digital hospital environment. Prior to joining PricewaterhouseCoopers LLP he worked in government relations, legislative and regulatory consulting, and policy analysis in Texas, Washington D.C. and internationally. He received a Master of Public Affairs from the Lyndon B. Johnson School of Public Affairs, University of Texas at Austin and a Bachelor of Arts, Government and Middle Eastern Studies from the University of Texas at Austin.

 
 
 
 
1101 Standiford Ave. Suite C-3 Modesto, CA 95350
Phone 209.577.4888  | e-Mail
infohws@healthwebsummit.com  |  Fax 209.577.3557
copyright , MCOL All rights reserved. Terms of Use apply to this site and participation in events.